DE69034053D1 - Transformation von tierischen somatischen zellen mittels partikeln - Google Patents

Transformation von tierischen somatischen zellen mittels partikeln

Info

Publication number
DE69034053D1
DE69034053D1 DE69034053T DE69034053T DE69034053D1 DE 69034053 D1 DE69034053 D1 DE 69034053D1 DE 69034053 T DE69034053 T DE 69034053T DE 69034053 T DE69034053 T DE 69034053T DE 69034053 D1 DE69034053 D1 DE 69034053D1
Authority
DE
Germany
Prior art keywords
animals
transformation
particle
somatic cells
spark discharge
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE69034053T
Other languages
English (en)
Other versions
DE69034053T2 (de
Inventor
J Brill
E Mccabe
Ning-Sun Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Powderject Vaccines Inc
Original Assignee
Powderject Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27005554&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69034053(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Powderject Vaccines Inc filed Critical Powderject Vaccines Inc
Application granted granted Critical
Publication of DE69034053D1 publication Critical patent/DE69034053D1/de
Publication of DE69034053T2 publication Critical patent/DE69034053T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • C12M35/02—Electrical or electromagnetic means, e.g. for electroporation or for cell fusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/89—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
    • C12N15/895—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection using biolistic methods

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Electromagnetism (AREA)
  • Cell Biology (AREA)
  • Sustainable Development (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicinal Preparation (AREA)
DE69034053T 1989-06-26 1990-06-21 Transformation von tierischen somatischen zellen mittels partikeln Revoked DE69034053T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37186989A 1989-06-26 1989-06-26
US49493390A 1990-03-14 1990-03-14
PCT/US1990/003522 WO1991000359A1 (en) 1989-06-26 1990-06-21 Particle-mediated transformation of animal somatic cells

Publications (2)

Publication Number Publication Date
DE69034053D1 true DE69034053D1 (de) 2003-04-30
DE69034053T2 DE69034053T2 (de) 2003-12-04

Family

ID=27005554

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69034053T Revoked DE69034053T2 (de) 1989-06-26 1990-06-21 Transformation von tierischen somatischen zellen mittels partikeln

Country Status (10)

Country Link
US (2) US20020081739A1 (de)
EP (1) EP0431135B1 (de)
JP (2) JP3573454B2 (de)
AT (1) ATE235558T1 (de)
AU (2) AU5856790A (de)
CA (1) CA2019676C (de)
DE (1) DE69034053T2 (de)
DK (1) DK0431135T3 (de)
ES (1) ES2194834T3 (de)
WO (1) WO1991000359A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6964191A (en) 1989-11-16 1991-06-13 Cornell Research Foundation Inc. Particle-mediated transformation of animal tissue cells
US5149655A (en) * 1990-06-21 1992-09-22 Agracetus, Inc. Apparatus for genetic transformation
CA2082262A1 (en) * 1991-03-06 1992-09-07 Dennis E. Mccabe Particle mediated transformation of cotton
CA2098498A1 (en) * 1991-10-15 1993-04-16 Ning-Sun Yang Particle-mediated transformation of mammalian unattached cells
WO1993008292A1 (en) * 1991-10-16 1993-04-29 Agracetus, Inc. Particle-mediated transformation of animal somatic cells
US5260191A (en) * 1992-01-30 1993-11-09 Agracetus, Inc. Method for diagnosing tumors
WO1993017697A1 (en) * 1992-03-04 1993-09-16 Wolff Jon A Method of delivering therapeutic substances to the brain
EP0584348B1 (de) * 1992-03-11 2005-05-18 Powderject Vaccines, Inc. Genetischer impfstoff gegen den immunschwäche virus
WO1993024626A1 (en) * 1992-05-28 1993-12-09 Scientific Dimensions Usa, Inc. Transgenic animal production with biolistically transformed spermatozoa
EP0706576A1 (de) * 1993-06-30 1996-04-17 Dcv Biologics L.P. Eine methode zur ineinfühlung von einem biologische stoff in ein ziel
GB2282139A (en) * 1993-09-24 1995-03-29 Univ Reading Introducing DNA into the germ line of birds
US6995008B1 (en) 1994-03-07 2006-02-07 Merck & Co., Inc. Coordinate in vivo gene expression
US7223739B1 (en) 1995-06-07 2007-05-29 Powderject Vaccines, Inc. Adjuvanted genetic vaccines
WO1997023502A1 (fr) * 1995-12-21 1997-07-03 Solvay (Societe Anonyme) Vaccin plasmidique contre le virus pseudorabique
BE1010344A3 (fr) * 1996-06-12 1998-06-02 Solvay Vaccin plasmidique contre le virus pseudorabique.
WO2000011181A1 (en) 1998-08-20 2000-03-02 Connaught Laboratories Limited NUCLEIC ACID MOLECULES ENCODING INCLUSION MEMBRANE PROTEIN C OF $i(CHLAMYDIA)
US6693087B1 (en) 1998-08-20 2004-02-17 Aventis Pasteur Limited Nucleic acid molecules encoding POMP91A protein of Chlamydia
US6686339B1 (en) 1998-08-20 2004-02-03 Aventis Pasteur Limited Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
US6881723B1 (en) 1998-11-05 2005-04-19 Powderject Vaccines, Inc. Nucleic acid constructs
US7022320B1 (en) 1999-02-09 2006-04-04 Powderject Vaccines, Inc. Mycobacterium tuberculosis immunization
US7196066B1 (en) 1999-11-03 2007-03-27 Powderject Vaccines, Inc. DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
EP1792995A3 (de) 2000-05-08 2007-06-13 Sanofi Pasteur Limited Chlamydia Antigene, entsprechende DNS Fragmente und ihre Verwendungen
WO2001085932A2 (en) 2000-05-10 2001-11-15 Aventis Pasteur Limited Immunogenic polypeptides encoded by mage minigenes and uses thereof
GB0201736D0 (en) * 2002-01-25 2002-03-13 Glaxo Group Ltd DNA dosage forms
ES2285087T3 (es) * 2002-01-25 2007-11-16 Glaxo Group Limited Formas farmaceuticas de adn.
EP1356820A1 (de) 2002-04-26 2003-10-29 Institut National De La Sante Et De La Recherche Medicale (Inserm) DNA-Impfstoff kombiniert mit einen Apoptoneauslöser von Tumorzellen
EP2411519B1 (de) 2009-03-27 2015-07-22 Institut National de la Santé et de la Recherche Médicale Kanamycin-antisense-nucleinsäure zur behandlung von krebs
EP2576613A1 (de) 2010-06-07 2013-04-10 Pfizer Inc. Her-2-peptide und impfstoffe
US20220135937A1 (en) 2018-12-20 2022-05-05 National University Corporation Toyohashi University Of Technology Electroporation device and method for producing cells with introduced foreign substance
IT201900007060A1 (it) 2019-05-21 2020-11-21 St Superiore Di Sanita Cellule tumorali ingegnerizzate e loro usi
IT201900012540A1 (it) 2019-07-22 2021-01-22 Humanitas Mirasole Spa Inibitori di CHI3L1 e loro usi
WO2022040334A1 (en) 2020-08-18 2022-02-24 Enviro Metals, LLC Metal refinement

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945050A (en) * 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
IL84459A (en) * 1986-12-05 1993-07-08 Agracetus Apparatus and method for the injection of carrier particles carrying genetic material into living cells
US5015580A (en) * 1987-07-29 1991-05-14 Agracetus Particle-mediated transformation of soybean plants and lines
US5149655A (en) * 1990-06-21 1992-09-22 Agracetus, Inc. Apparatus for genetic transformation
US5405779A (en) * 1993-04-09 1995-04-11 Agracetus, Inc. Apparatus for genetic transformation
US5506125A (en) * 1993-12-22 1996-04-09 Agracetus, Inc. Gene delivery instrument with replaceable cartridges

Also Published As

Publication number Publication date
CA2019676A1 (en) 1990-12-26
US20020081739A1 (en) 2002-06-27
DK0431135T3 (da) 2003-07-21
WO1991000359A1 (en) 1991-01-10
AU679477B2 (en) 1997-07-03
DE69034053T2 (de) 2003-12-04
ATE235558T1 (de) 2003-04-15
JP3573454B2 (ja) 2004-10-06
CA2019676C (en) 2005-08-09
JP2001213807A (ja) 2001-08-07
AU5787394A (en) 1994-05-19
US20050216959A1 (en) 2005-09-29
JPH04500314A (ja) 1992-01-23
EP0431135B1 (de) 2003-03-26
EP0431135A1 (de) 1991-06-12
ES2194834T3 (es) 2003-12-01
AU5856790A (en) 1991-01-17

Similar Documents

Publication Publication Date Title
DE69034053D1 (de) Transformation von tierischen somatischen zellen mittels partikeln
US5318514A (en) Applicator for the electroporation of drugs and genes into surface cells
BRPI0411817A (pt) aparelho e método para estimulação bioelétrica, aceleração da cura, alìvio da dor ou desvitalização de patógenos
ATE179339T1 (de) Elektrische stimulierung zur behandlung von inkontinenz und anderen neuromuskularerkrankungen
ES2116986T3 (es) Composiciones de metal-peptidos y metodos cosmeticos para estimular el crecimiento del cabello.
DE69022290D1 (de) Lebende Impfstoffe.
DK0559884T3 (da) Rekombinante virusvektorer til ekspression i muskelceller
SE9401091D0 (sv) Alphavirus cDNA vectors
BR0207399A (pt) Método de terapia com células para o tratamento de tumores
DE3876756T2 (de) Vorrichtung zur gesteuerten freigabe und verabreichung von wirkstoffen an tierisches gewebe.
Bullmann et al. A transportable, inexpensive electroporator for in utero electroporation
DE69833876D1 (de) Zusammensetzungen und methoden zur zielgerichteten abgabe von biologisch aktivenfaktoren
NO932101D0 (no) Polypeptidmateriale som er anvendelig ved terapeutisk behandling av mennesker
Erndt-Marino et al. Membrane potential controls macrophage activation
CN111172151A (zh) 一种电信号通过调节皮肤DCs/LCs提呈至T细胞而调控机体免疫反应的方法及其用途
HARTLEY et al. Experimental osteogenesis in rabbit muscle
SU1713600A1 (ru) Способ лечени диспепсии жвачных животных
Tenforde Biological effects of extremely-low-frequency magnetic fields
Raheel et al. Immune potentiating effect of bee venom on humoral parameters of innate immunity in broiler chickens.
Farsani et al. Gene therapy a new approach in dentistry: human or microbial gene modification
BLOOM UUL. 1iiLillIIiILIQILI1111. 1 Hl
Legon’kova et al. On the Effect of Products Made from Recombinant Spidroin Protein on Wound Regeneration in an Experiment
Hechavarria The BioDome regenerative sleeve: Biochemical and biophysical stimulation of murine digit regeneration
Dimitriadis et al. Effect of He-Ne laser on the midgut cells of Drosophila auraria larvae and its correlation with acupuncture
Kotnik et al. Potential therapeutic indications for synthetic desmuramyl MDP analogue (LK-409)

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation